ProKidney Corp.
PROK
$1.08
$0.054.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -273.23% | -63.06% | -37.16% | 1.79% | 12.12% |
| Total Depreciation and Amortization | 37.35% | 47.86% | 45.98% | 32.45% | 44.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.96% | 36.27% | -22.16% | -38.97% | -170.44% |
| Change in Net Operating Assets | 349.55% | -104.57% | -180.66% | -137.49% | 524.92% |
| Cash from Operations | 4.78% | -22.98% | -156.72% | -33.29% | -61.06% |
| Capital Expenditure | -1,522.71% | 91.40% | 82.81% | 2.64% | -413.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 143.06% | -18,114.02% | 408.96% | 130.98% | -- |
| Cash from Investing | 115.73% | -187.71% | 317.21% | 130.32% | -31,221.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.69% | -7.69% | 0.00% | 0.00% | -62.50% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 101.29% | 34,376.92% | 1,075,807.69% | 0.00% | -118,800.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.14% | -104.01% | 563.35% | 110.86% | -713.31% |